This new report from VPGMarketResearch.com provides analysis of CA 15-3/27-29 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USA
Market Segmentation
Centralized Testing
- Hospitals
- Commercial/Private Laboratories
POC/Decentralized Testing
- Physician Offices/Group Practices
- Cancer Clinics
List of Tables
List of Tables
France: CA 15-3/27-29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: CA 15-3/27-29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: CA 15-3/27-29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: CA 15-3/27-29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: CA 15-3/27-29 Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: CA 15-3/27-29 Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: CA 15-3/27-29 Test Volume and Diagnostics Sales Forecasts by Market Segment
